Literature DB >> 1637562

Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis.

M J Kerscher1, H C Korting.   

Abstract

24 healthy volunteers with no history of skin disease were entered in a 6-week double-blind randomized study to compare the atrophogenicity potentials of both cream and ointment forms of triamcinolone acetonide and clobetasol propionate. The atrophogenicity potential of cream preparations turned out to be greater than that of ointment preparations containing identical amounts of the same glucocorticoid. This result proves both the reproducibility of the assay and the general character of the phenomenon in view of the limited previous evidence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637562     DOI: 10.1159/000211022

Source DB:  PubMed          Journal:  Skin Pharmacol        ISSN: 1011-0283


  4 in total

Review 1.  Clinical evidence: atopic eczema.

Authors:  C Charman
Journal:  BMJ       Date:  1999-06-12

2.  Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.

Authors:  A Gysler; K Lange; H C Korting; M Schäfer-Korting
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

Review 3.  Pruritus ani.

Authors:  S Siddiqi; V Vijay; M Ward; R Mahendran; S Warren
Journal:  Ann R Coll Surg Engl       Date:  2008-09       Impact factor: 1.891

Review 4.  The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.

Authors:  Emma Harris; Ana Tiganescu; Sandy Tubeuf; Sarah Louise Mackie
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.